2022

Bringing synthetic biology to the market: an Australia and Singapore perspective

2022-09-27T15:09:29+08:00

In partnership with Synthetic Biology Australasia, SINERGY organized a webinar on “Bringing synthetic biology to market: an Australia and Singapore perspective” on Tuesday, 2 August 2022. Here you can watch recordings of the startup and investor panel discussions from the webinar, and gain insights into what entrepreneurs and founders from Australia and Singapore had to say.

Bringing synthetic biology to the market: an Australia and Singapore perspective2022-09-27T15:09:29+08:00

SINERGY speaks to Emily Leproust from Twist Bioscience

2022-07-13T13:36:09+08:00

What is the secret of successful Synthetic Biology company? According to Emily Leproust, CEO of Twist Bioscience, it all depends on people. In this interview, Sierin Lim explores the journey of Emily Leproust as a scientist and entrepreneur, how Twist was made, what motivated her, as well as her advice to aspiring scientists and entrepreneurs in Biotech and Synthetic Biology.

SINERGY speaks to Emily Leproust from Twist Bioscience2022-07-13T13:36:09+08:00

Combining synthetic, computational, and structural biology improves key enzyme in cannabinoid biosynthesis

2022-05-18T12:58:46+08:00

While cannabis plants are best known for the psychotropic effects of THC, Cannabis sativa contains a wealth of secondary metabolites. Many of these compounds, known under the umbrella term “cannabinoids”, have potential applications as therapeutics.

Combining synthetic, computational, and structural biology improves key enzyme in cannabinoid biosynthesis2022-05-18T12:58:46+08:00

SINERGY Speaks to Julius Fredens From NUS

2022-04-28T14:10:59+08:00

Julius Fredens is one of the newest members of Singapore’s synbio community. After obtaining his PhD from University of Southern Denmark, he moved to the MRC Laboratory of Molecular Biology in Cambridge to work with Professor Jason Chin on genetic code compression.

SINERGY Speaks to Julius Fredens From NUS2022-04-28T14:10:59+08:00

NUS SynCTI Launches SynbioResources To Support Singapore’s Synthetic Biology Community

2022-04-28T13:50:46+08:00

To encourage reuse and reproducibility in the synthetic biology community, the National University of Singapore (NUS) Synthetic Biology for Clinical and Technological Innovation (SynCTI) has established SynbioResources, a digital collection of databases and tools related to synthetic biology.

NUS SynCTI Launches SynbioResources To Support Singapore’s Synthetic Biology Community2022-04-28T13:50:46+08:00

SINERGY Speaks to Ching Leang From LanzaTech

2022-04-13T17:17:21+08:00

One of the most unexpected food for microbes is carbon-rich gas. LanzaTech, a company founded in New Zealand and based in Illinois, USA, decided to challenge this conventional wisdom. By recycling carbon from...

SINERGY Speaks to Ching Leang From LanzaTech2022-04-13T17:17:21+08:00
Go to Top